Track topics on Twitter Track topics that are important to you
Adds Servo Drives to Complement Its Encoders, Motors and Mechatronics
Celera Motion, a business unit of Novanta Corporation, announces the acquisition of Ingenia, which develops and manufactures servo drives and control software. This acquisition significantly enhances Celera Motion’s precision motion capabilities.
Based in Barcelona, Spain, Ingenia provides original equipment manufacturers (OEMs) with customized motion control solutions based on high performance and high power servo drive technology. Celera Motion provides medical and advanced industrial OEM customers with precision optical and inductive encoders, motors and actuators, and mechatronics solutions.
“Ingenia’s products complement the Celera Motion products, and we’re excited to bring these talented and innovative teams together,” said Leane Sinicki, Precision Motion Group President, Novanta. “This acquisition expands and enhances our offering as we help our customers solve their most complex motion challenges.”
About Celera Motion
Celera Motion, headquartered in Bedford, Massachusetts, is a market leading provider of motion control components and subsystems for OEMs serving a variety of medical and advanced industrial markets. Celera Motion offers precision encoders, motors, and customized mechatronic solutions that help customers solve challenging motion control problems. For more information, visit www.celeramotion.com.
Novanta is a trusted technology partner to OEMs in the medical and advanced industrial technology markets, with deep proprietary expertise in photonics, vision and precision motion technologies. For more information, visit www.novanta.com.
Celera Motion, A Novanta Company
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...